Revenue, last quarter
$395K
−42.2% vs same quarter last year
Net income
−$41.2M
−22.1% vs same quarter last year
EPS, diluted
−$0.75
−19% vs same quarter last year
Operating cash flow
−$54.2M
−143.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.9M | −$143.4M |
| FY24 | $2.4M | −$62.8M |
| FY23 | $2.4M | −$20.5M |
| FY22 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −5618.8% | −5026% |
| FY24 | −3281.2% | −2650% |
| FY23 | −1685.5% | −862.9% |
| FY22 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$133.4M |
| FY24 | −$59.7M |
| FY23 | −$38.1M |
| FY22 | - |
- Upstream Bio
- Healthcare median
Show the numbers
| Year | Upstream Bio | Healthcare median |
|---|---|---|
| FY25 | −5026% | −30.6% |
| FY24 | −2650% | −47% |
| FY23 | −862.9% | −58% |
| FY22 | - | −80.4% |